JAMA· 2020Q1

Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders

Sebastian Palmqvist, Shorena Janelidze, Yakeel T. Quiroz, Henrik Zetterberg et al.

1,572citations
Q1SCImago
2020year

Short summary

Plasma phospho-tau217 (P-tau217) accurately distinguishes Alzheimer's disease (AD) from other neurodegenerative disorders, achieving diagnostic performance comparable to cerebrospinal fluid (CSF) and PET scans.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Psychiatry and Mental health

Psychiatry and Mental healthMedicine